Personal information

No personal information available

Activities

Collapse all

Works (9)

New 1,2,3-triazole linked ciprofloxacin-chalcones induce DNA damage by inhibiting human topoisomerase I& II and tubulin polymerization.

Journal of enzyme inhibition and medicinal chemistry
2022-12-01 | Journal article
DOI: 10.1080/14756366.2022.2072308
PMID: 35548854
PMC: PMC9116245
Source: Self-asserted source
Aml Imam Mekkawy

Evaluation of Different Surface Coating Agents for Selenium Nanoparticles: Enhanced Anti-Inflammatory Activity and Drug Loading Capacity.

Drug design, development and therapy
2022-06-13 | Journal article
DOI: 10.2147/dddt.s360344
PMID: 35719212
PMC: PMC9205440
Source: Self-asserted source
Aml Imam Mekkawy

Chitosan Nanoparticles for Meloxicam Ocular Delivery: Development, In Vitro Characterization, and In Vivo Evaluation in a Rabbit Eye Model.

Pharmaceutics
2022-04-20 | Journal article
DOI: 10.3390/pharmaceutics14050893
PMID: 35631479
PMC: PMC9148062
Source: Self-asserted source
Aml Imam Mekkawy

The MEK 1/2 inhibitor PD98059 exhibits synergistic anti-endometrial cancer activity with paclitaxel in vitro and enhanced tissue distribution in vivo when formulated into PAMAM-coated PLGA-PEG nanoparticles.

Drug delivery and translational research
2021-10-11 | Journal article
DOI: 10.1007/s13346-021-01065-7
PMID: 34635984
Source: Self-asserted source
Aml Imam Mekkawy

Paclitaxel anticancer activity is enhanced by the MEK 1/2 inhibitor PD98059 in vitro and by PD98059-loaded nanoparticles in BRAF<sup>V600E</sup> melanoma-bearing mice.

International journal of pharmaceutics
2021-07-10 | Journal article
DOI: 10.1016/j.ijpharm.2021.120876
PMID: 34252520
Source: Self-asserted source
Aml Imam Mekkawy

DEVELOPMENT AND OPTIMIZATION OF ALBENDAZOLE NANOSUSPENSION AS LOCAL ADJUVANT THERAPY FOR TREATMENT OF ENTEROBIASIS

Bulletin of Pharmaceutical Sciences. Assiut
2020-12-04 | Journal article
DOI: 10.21608/bfsa.2020.127397
Part of ISSN: 1110-0052
Source: Self-asserted source
Aml Imam Mekkawy

An Injectable Microparticle Formulation Provides Long-Term Inhibition of Hypothalamic ERK1/2 Activity and Sympathetic Excitation in Rats with Heart Failure.

Molecular pharmaceutics
2020-08-04 | Journal article
DOI: 10.1021/acs.molpharmaceut.0c00501
PMID: 32786958
PMC: PMC7641013
Source: Self-asserted source
Aml Imam Mekkawy

In vitro and in vivo evaluation of biologically synthesized silver nanoparticles for topical applications: effect of surface coating and loading into hydrogels.

International journal of nanomedicine
2017-01-23 | Journal article
DOI: 10.2147/ijn.s124294
PMID: 28176951
PMC: PMC5271388
Source: Self-asserted source
Aml Imam Mekkawy

Silver Nanoparticles-loaded Hydrogels, A Potential Treatment for Resistant Bacterial Infection and Wound Healing: A Review

British Journal of Pharmaceutical Research
2016-01-10 | Journal article
DOI: 10.9734/bjpr/2016/30525
Part of ISSN: 2231-2919
Source: Self-asserted source
Aml Imam Mekkawy
How many people are using ORCID?